Pulmonary Arterial Hypertension
📧 Sign up to get email alerts when something new happens for Pulmonary Arterial Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-05-20Clinical Trial Update: Study of Cardiac MRI in the Follow up Assessment of Patients With PAH (EVITA) [NA]
The document provides an update on a clinical trial (EVITA) studying cardiac MRI for follow-up in patients with pulmonary arterial hypertens…
-
CLINICAL_TRIALS trial_result · 2024-05-17Clinical Trial Update: Exercise Hemodynamic, Right Ventricular Coupling and Echocardiography in Pulmonary Hypertension
Completed clinical trial update evaluating exercise hemodynamics, right ventricular coupling, and echocardiography in pulmonary hypertension…
-
CLINICAL_TRIALS trial_result · 2024-05-17Clinical Trial Update: Right Atrial Fibrosis in Pulmonary Hypertension
A ClinicalTrials.gov update indicates a completed study on right atrial fibrosis in pulmonary hypertension, including chronic thromboembolic…
-
CLINICAL_TRIALS research · 2024-05-16Clinical Trial Update: IntelliStent for Pulmonary Flow Adjustment in Congenital Heart Disease and Dilated Cardiomyopathy [NA]
This clinical trial update describes the IntelliStent being studied for pulmonary flow adjustment in patients with congenital heart disease …
-
CLINICAL_TRIALS research · 2024-05-10Clinical Trial Update: COMPression of Left Main coRonary artEry in patientS With Pulmonary Arterial Hypertension aSymptomatIc fOr aNgina [NA]
A clinical trial investigating compression of the left main coronary artery in patients with pulmonary arterial hypertension who have angina…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-05-08Clinical Trial Update: Validation of a Machine Learning Predictive Model to Distinguish Post-capillary Pulmonary Hypertension
Clinical trial update reporting validation of a machine learning model to distinguish post-capillary pulmonary hypertension, currently recru…
-
CLINICAL_TRIALS research · 2024-05-03Clinical Trial Update: Utility of At-home Monitoring of Exercise Capacity by App-based 6-minute Walk Test [NA]
This clinical trial update describes the use of an at-home, app-based 6-minute walk test to monitor exercise capacity in patients with pulmo…
-
CLINICAL_TRIALS trial_result · 2024-05-01Clinical Trial Update: Pulmonary Hypertension and Anastrozole Trial [Phase 2]
Phase 2 trial evaluating anastrozole for pulmonary arterial hypertension has completed and results have been posted.
-
FDA approval · 2024-04-11FDA Approved: OPSUMIT — Supplemental Application (Actelion Pharmaceuticals US, Inc.)
FDA approved a supplemental application for OPSUMIT (macitentan) submitted by Actelion Pharmaceuticals US, Inc.
-
FDA approval · 2024-03-22FDA Approved: OPSYNVI — Original Application (Actelion Pharmaceuticals US, Inc.)
FDA approved OPSYNVI, a fixed-dose combination of macitentan and tadalafil, under Original Application NDA218490 for pulmonary arterial hype…
-
FDA approval · 2024-03-19FDA Approved: TRYVIO — Original Application (Idorsia Pharmaceuticals Ltd)
FDA approves TRYVIO (aprocitentan) from Idorsia in an Original Application (NDA217686) for the treatment of pulmonary arterial hypertension.
-
CLINICAL_TRIALS trial_result · 2024-03-19Clinical Trial Update: Initial Triple Therapy Including Parenteral Treprostinil vs Initial Double Oral Therapy in PAH Group I Patients [Phase 4]
A Phase 4 trial comparing initial triple therapy including parenteral treprostinil versus initial double oral therapy in patients with pulmo…
-
FDA approval · 2024-03-14FDA Approved: TREPROSTINIL — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for TREPROSTINIL water solution from Sandoz Inc, approving a new formulation of treprostinil.
-
CLINICAL_TRIALS trial_result · 2024-02-20Clinical Trial Update: Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM) - PDE5
The DREAM study evaluating a phosphodiesterase-5 inhibitor for Alzheimer's medicines has completed data analysis, with results posted on 202…
-
CLINICAL_TRIALS trial_result · 2024-02-20Clinical Trial Update: A Study to Investigate the Efficacy of PADN to Improved Functional Capacity and Hemodynamics in Patients With PAH [Phase 4]
Phase 4 trial investigating PADN for improving functional capacity and hemodynamics in pulmonary arterial hypertension was terminated.
-
CLINICAL_TRIALS trial_result · 2024-02-14Clinical Trial Update: REstoration of VItamin D in Pulmonary Arterial Hypertension [Phase 4]
Phase 4 clinical trial investigating restoration of vitamin D in patients with pulmonary arterial hypertension and vitamin D deficiency; not…
-
FDA approval · 2024-02-13FDA Approved: AURLUMYN — Original Application (BTG International Inc)
FDA approved AURLUMYN (iloprost) through an original NDA from BTG International Inc. The approval establishes a new iloprost product for its…
-
FDA label_change · 2024-02-08FDA Approved: TRACLEER — Supplemental Application (Actelion Pharmaceuticals US, Inc.)
FDA approved a supplemental application for TRACLEER (bosentan) to update the labeling. Bosentan is used to treat pulmonary arterial hyperte…
-
FDA label_change · 2024-02-08FDA Approved: TRACLEER — Supplemental Application (Actelion Pharmaceuticals US, Inc.)
The FDA approved a supplemental application for TRACLEER (bosentan) to update its labeling, submitted by Actelion Pharmaceuticals US, Inc.
-
CLINICAL_TRIALS trial_result · 2024-02-07Clinical Trial Update: Anti-CD20 Antibodies for Treatment of SLE-PAH [Phase 4]
Phase 4 clinical trial update evaluating anti-CD20 antibodies for treatment of systemic lupus erythematosus-associated pulmonary arterial hy…
-
CLINICAL_TRIALS trial_result · 2023-11-13Clinical Trial Update: Clinical Study to Compare the Efficacy and Safety of Macitentan and Tadalafil Monotherapies With the Corresponding Fixed-dose Combination Therapy in Subjects With Pulmonary Arterial Hypertension (PAH) [Phase 3]
Phase 3 clinical study comparing macitentan and tadalafil monotherapies with a fixed-dose combination in pulmonary arterial hypertension. Re…
-
CLINICAL_TRIALS trial_result · 2023-11-07Clinical Trial Update: GB002 in Adult Subjects With Pulmonary Arterial Hypertension (PAH) [Phase 2]
Phase 2 trial update for GB002 in adults with pulmonary arterial hypertension has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-10-24Clinical Trial Update: A Study of Ralinepag to Evaluate Effects on Exercise Capacity by CPET in Subjects With WHO Group 1 PH [Phase 3]
Phase 3 trial evaluating ralinepag effects on exercise capacity in pulmonary arterial hypertension (PAH) was terminated.
-
CLINICAL_TRIALS trial_result · 2023-10-10Clinical Trial Update: Positioning Imatinib for Pulmonary Arterial Hypertension [Phase 2]
Phase 2 clinical trial exploring imatinib for pulmonary arterial hypertension is in early stages with unknown status.
-
CLINICAL_TRIALS trial_result · 2023-09-22Clinical Trial Update: A Study of Treprostinil Palmitil Inhalation Powder (TPIP) In Pulmonary Arterial Hypertension (PAH) [Phase 2]
Phase 2 trial of Treprostinil Palmitil Inhalation Powder (TPIP) for pulmonary arterial hypertension has been terminated; results posted in 2…